WallStreetZenWallStreetZen

NASDAQ: IMCR
Immunocore Holdings PLC Stock

$41.49+2.02 (+5.12%)
Updated Jul 16, 2024
IMCR Price
$41.49
Fair Value Price
N/A
Market Cap
$2.07B
52 Week Low
$33.05
52 Week High
$76.98
P/E
-34.72x
P/B
5.77x
P/S
12.27x
PEG
N/A
Dividend Yield
N/A
Revenue
$264.25M
Earnings
-$58.85M
Gross Margin
99.6%
Operating Margin
-21.63%
Profit Margin
-22.3%
Debt to Equity
1.77
Operating Cash Flow
-$478k
Beta
0.75
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IMCR Overview

Immunocore Holdings plc develops immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. It offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Other oncology programs include IMC-C103C, in Phase I/II dose escalation trials in patients with solid tumor cancers (non-small-cell lung, gastric, head and neck, ovarian, and synovial sarcoma cancers), and IMC-F106C, in Phase I/II dose escalation trials in patients with multiple solid tumor cancers (non-small-cell lung, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers). Immunocore was founded in 1999 and is headquartered in Abingdon, UK.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IMCR scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IMCR is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IMCR is good value based on its book value relative to its share price (5.77x), compared to the US Biotechnology industry average (6.51x)
P/B vs Industry Valuation
IMCR is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more IMCR due diligence checks available for Premium users.

Be the first to know about important IMCR news, forecast changes, insider trades & much more!

IMCR News

Valuation

IMCR fair value

Fair Value of IMCR stock based on Discounted Cash Flow (DCF)
Price
$41.49
Fair Value
-$0.33
Undervalued by
12,493.49%
IMCR is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IMCR price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-34.72x
Industry
-18x
Market
31.71x

IMCR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
5.77x
Industry
6.51x
IMCR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IMCR's financial health

Profit margin

Revenue
$70.5M
Net Income
-$24.4M
Profit Margin
-34.7%
IMCR's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
IMCR's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$994.0M
Liabilities
$634.5M
Debt to equity
1.77
IMCR's short-term assets ($926.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMCR's short-term assets ($926.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMCR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.6M
Investing
-$430.0k
Financing
$396.0M
IMCR's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IMCR vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IMCR$2.07B+5.12%-34.72x5.77x
EWTX$2.07B-2.93%-14.32x3.88x
GPCR$2.08B+0.31%-19.59x4.84x
RXRX$2.04B+4.88%-5.31x5.10x
SNDX$2.11B+1.76%-7.68x4.29x

Immunocore Holdings Stock FAQ

What is Immunocore Holdings's quote symbol?

(NASDAQ: IMCR) Immunocore Holdings trades on the NASDAQ under the ticker symbol IMCR. Immunocore Holdings stock quotes can also be displayed as NASDAQ: IMCR.

If you're new to stock investing, here's how to buy Immunocore Holdings stock.

What is the 52 week high and low for Immunocore Holdings (NASDAQ: IMCR)?

(NASDAQ: IMCR) Immunocore Holdings's 52-week high was $76.98, and its 52-week low was $33.05. It is currently -46.1% from its 52-week high and 25.56% from its 52-week low.

How much is Immunocore Holdings stock worth today?

(NASDAQ: IMCR) Immunocore Holdings currently has 50,011,610 outstanding shares. With Immunocore Holdings stock trading at $41.49 per share, the total value of Immunocore Holdings stock (market capitalization) is $2.07B.

Immunocore Holdings stock was originally listed at a price of $56.34 in Feb 8, 2021. If you had invested in Immunocore Holdings stock at $56.34, your return over the last 3 years would have been -26.36%, for an annualized return of -9.7% (not including any dividends or dividend reinvestments).

How much is Immunocore Holdings's stock price per share?

(NASDAQ: IMCR) Immunocore Holdings stock price per share is $41.49 today (as of Jul 16, 2024).

What is Immunocore Holdings's Market Cap?

(NASDAQ: IMCR) Immunocore Holdings's market cap is $2.07B, as of Jul 17, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Immunocore Holdings's market cap is calculated by multiplying IMCR's current stock price of $41.49 by IMCR's total outstanding shares of 50,011,610.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.